Burkhoideria cepacia complex infection in patients with cystic fibrosis: Laboratory investigations, epidemiology and clinical management

Reviews and Research in Medical Microbiology

Volumn 14, Issue 1, 2003, Pages 15-24

  Ryley, Henry C ^a   Doull, Iolo J M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Burkholderia cepacia diagnosis; Infections in cystic fibrosis

Indexed keywords

AGAR; AMIKACIN; CEFTAZIDIME; CHLORAMPHENICOL; MEROPENEM; MINOCYCLINE; POLYMYXIN B; RNA 16S; RNA 23S; TICARCILLIN; TOBRAMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BURKHOLDERIA CEPACIA; CROSS INFECTION; CYSTIC FIBROSIS; DEATH; DRUG EFFICACY; EPIDEMIC; HUMAN; INCIDENCE; LUNG INFECTION; LUNG TRANSPLANTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SPECIES DIFFERENTIATION; TAXONOMY;

EID: 0037241321     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-200301000-00002     Document Type: Review

References (84)

1. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245:1066-1072.
2. Dbring G, Conway SP, Heijerman HGM, Hodson ME, Hoiby N, Smyth A, Touw DJ for the Consensus Committee. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000;16:749-767.
3. Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995;73:117-120.
4. Hiatt PW, Grace SC, Kozinetz CA, Raboudi SH, Treece DG, Taber LH, et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999; 103:619-626.
5. Johansen HK, Høiby N. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992; 47:109-111.
6. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104:206-210.
7. Tablan OC, Chorba TL, Schidlow DV, White JW, Hardy KA, Gilligan PH, et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985; 107:382-387.
8. Thomassen MJ, Demko CA, Klinger JD, Stern RC. Pseudomonas cepacia colonization amongst patients with cystic fibrosis; a new opportunist. Am Rev Respir Dis 1985; 131:791-796.
9. Burkholder WH. Sour skin, a bacterial rot of onion bulbs. Phytopathology 1950; 40:115-117.
10. Sinsabaugh HA, Howard GW. Emendation of the description of Pseudomonas cepacia Burkholderia (synonyms: Pseudomonas multivorans Stanier et al., Pseudomonas kingii Jonsson: EO1 group). Intl J System Bacteriol 1975; 25:187-201.
11. Simmonds EJ, Conway SP, Ghoneim ATM, Ross H, Littlewood JM. Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child 1990; 65:874-877.
12. Palleroni NJ, Kunisawa R, Contopoulou R, Doudoroff M. Nucleic acid homologies in the genus Pseudomonas. Intl J System Bacteriol 1973; 23:333-339.
13. Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, Hashimoto Y, et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology Group II to the new genus with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 1992; 36:1251-1275.
14. Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp.nov. Ind J System Bacteriol 1997; 47:1188-1200.
15. Vandamme P, Mahenthiralingam E, Holmes B, Coenye T, Hoste B, de Vos P, et al. Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia Genomovar IV). J Clin Microbiol 2000; 38:1042-1047.
16. Coenye T, LiPuma JJ, Henry D, Hoste B, Vandemeulebroecke K, Gillis M, et al. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients. Intl J System Evol Microbiol 2001; 51:271-279.
17. Coenye T, Mahenthiralingam E, Henry D, Li Puma JJ, Laevens S, Gillis M, et al. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Intl J System Evol Microbiol 2001; 51:1481-1490.
18. Vandamme P, Henry D, Coenye T, Nzula S, Vancanneyt M, LiPuma JJ, et al. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol 2002; 32:143-149.
19. Coenye T, Vandamme P, Govan JRW, LiPuma JJ. Taxonomy and identification of Burkholderia cepacia complex. J Clin Microbiol 2001; 39:3427-3436.
20. Gilligan PH, Gage PA, Bradshaw LM, Schidlow DV, DeCicco BT. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 1985; 22:5-8.
21. Henry DA, Campbell ME, LiPuma JJ, Speert DP. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol 1997; 35:614-619.
22. Henry D, Campbell M, McGimpsey C, Clarke A, Louden L, Burns JL, et al. Comparison of Isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 1999; 37: 1004-1007.
23. Wright RM, Moore JE, Shaw A, Dunbar K, Dodd M, Webb K, et al. Improved culture detection of Burkholderia cepacia from sputum in patients with cystic fibrosis. J Clin Pathol 2001; 54:803-805.
24. Kiska DL, Kerr A, Jones MC, Caracciolo JA, Eskridge B, Jordan M, et al. Accuracy of four commercial systems for the identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol 1996; 34:886-891.
25. Shelly DB, Spilker T, Gracely EJ, Coenye T, Vandamme P, LiPuma JJ. Ultility of commercial systems for the identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J Clin Microbiol 2000; 38:3112-3115.
26. O'Callaghan EM, Tanner MS, Boulnois GJ. Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia. J Clin Pathol 1994; 47:222-226.
27. van Pelt C, Verduin CM, Goessens HF, Vos MC, Tümmler B, Segonds C, et al. Identification of Burkholderia spp. in clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol 1999; 37:2158-2164.
28. Campbell PW, Phillips JA, Heidecker GJ, Krishnamani MRS, Zahorchak R, Stull TL. Detection of Pseudomonas (Burkholderia) cepacia using PCR. Pediatr Pulmonol 1995; 20:44-49.
29. Tyler SD, Strathdee CA, Rozee KR, Johnson WM. Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of the sequencing of genes coding for 16S-23S rRNA internal transcribed spacers. Clin Diagnost Lab Immunol 1995; 2:448-453.
30. Clode FE, Kaufmann ME, Malnick H, Pitt TL. Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli. J Clin Pathol 1999; 52:173-176.
31. Whitby PW, Dick HLN, Campbell PW, Tullis DE, Matlow A, Stull T. Comparison of culture and PCR for the detection of Burkholderia cepacia in sputum specimens of patients with cystic fibrosis. J Clin Microbiol 1998; 36:1642-1645.
32. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, et al. DNA-based diagnostic approaches for the identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis and Burkholderia cepacia Genomovars I and III. J Clin Microbiol 2000; 38:3165-3173.
33. Mahenthiralingam E, Baldwin A, Vandamme P. Burkholderia cepacia complex in patients with cystic fibrosis. J Med Microbiol 2002; 51:533-538.
34. Bauernfeind A, Schneider I, Renate J, Roller C. Dicrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, IV by PCR. J Clin Microbiol 1999; 37:1335-1339.
35. LiPuma JJ, Dulaney BJ, McMenamin JD, Whitby PW, Stull TL, Coenye T, et al. Development of rRNA-based PCR assays for the identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol 1999; 37:3167-3170.
36. Segonds C, Heulin T, Marty N, Chabanon G. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates. J Clin Microbiol 1999; 37: 2201-2208.
37. Vermis K, Vandekerckhove C, Nelis HJ, Vandamme PAR. Evaluation of restricted fragment length polymorphism analysis of 16S rDNA as a tool for genomovar characterisation within the Burkholderia cepacia complex. FEMS Microbiol Lett 2002; 214:1-5.
38. Henry DA, Mahenthiralingam E, Vandamme P, Coenye T, Speert DP. Phenotypic methods for determining genomovar status of Burkholderia cepacia complex. J Clin Microbiol 2001; 39:1073-1078.
39. Dřvínek P, Hrbáčková H, Cinek O, Bartošová J, Nyč O, Nemec A, et al. Direct PCR detection of Burkholderia cepacia complex and identification of its genomovars by using sputum as source of DNA. J Clin Microbiol 2002; 40:3485-3488.
40. Vermis K, Coenye T, Mahenthiralingham E, Nelis HJ, Vandamme P. Evaluation of species-specific recA based PCR tests for genomovar level identification within the Burkholderia cepacia complex. J Med Microbiol 2002; 51:937-940.
41. Wilkinson SG, Pitt TL. Burkholderia (Pseudomonas) cepacia: surface chemistry and typing methods. Rev Med Microbiol 1995; 6:1-9.
42. Rabkin CS, Jarvis WR, Anderson RL, Govan J, Klinger J, LiPuma JJ, et al. Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis 1989; 11:600-607.
43. Larsen GY, Stull TL, Burns JL. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol 1993; 31:788-792.
44. LiPuma JJ, Mortensen JE, Dasen SE, Edlind TD, Schidlow DV, Burns JL et al. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centres. J Pediatr 1988; 113:859-862.
45. Anderson DJ, Kuhns JS, Vasil ML, Gerding DN, Janoff EN. DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol 1991; 29:648-649.
46. Coenye T, Spilker T, Martin A, LiPuma JJ. Comparative assessment of the genotyping methods for epidemiologic study of Burkholderia cepacia Genomovar III. J Clin Microbiol 2002; 40:3300-3307.
47. Mahenthiralingam E, Campbell ME, Henry DA, Speert DP. Epidemiology of Burkholderia cepacia infections in patients with cystic fibrosis: analysis by random amplified polymorphic DNA fingerprinting. J Clin Microbiol 1996; 34:2914-2920.
48. Tyler KD, Wang G, Tyler SD, Johnson WM. Factors affecting reliability and reproducibility of amplification-based DNA fingerprinting of representatives bacterial pathogens. J Clin Microbiol 1997; 35:339-346.
49. Kostman JR, Edlind TD, LiPuma JJ, Stull TL. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol 1992; 30:2084-2087.
50. Ryley HC, Millar-Jones L, Paull A, Weeks J. Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping. J Med Microbiol 1995; 43:436-441.
51. Ryley HC, Ojeniyi, Høiby N, Weeks J. Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1996; 15:755-758.
52. Liu P Y-F, Shi Z-Y, Lau Y-J, Hu B-S, Shyr J-M, Tsai W-S, et al. Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates. J Clin Microbiol 1995; 33:3304-3307.
53. Winstanley C, Detsika MG, Glendinning J, Parsons YN, Hart CA. Flagellin gene PCR-RFLP analysis of a panel of strains from Burkholderia cepacia complex. J Med Microbiol 2001; 50: 728-731.
54. Coenye T, LiPuma JJ. Multirestriction typing: a novel tool for the studying of global epidemiology of Burkholderia cepacia complex infections in cystic fibrosis. J Infect Dis 2002; 185: 1454-1462.
55. Sajjan U, Corey M, Humar A, Tullis E, Cutz E, Ackerley C, et al. Immunolocalisation of Burkholderia cepacia in the lungs of cystic fibrosis patients. J Med Microbiol 2001; 50:535-546.
56. Sun L, Jiang R-Z, Steinbach S, Holmes A, Campanelli C, Forstner J, et al. The emergence of a highly transmissible lineage of cbl= Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nature Med 1995; 1: 661-666.
57. Pitt TL, Kaufmann ME, Patel PS, Benge LCA, Gaskin S, Livermore DM. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol 1996; 44:203-210.
58. Holmes A, Nolan R, Taylor R, Finley R, Riley M, Jiang R-Z, et al. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis 1999; 179:1197-1205.
59. LiPuma JJ, Spilker T, Gill LH, Campbell PW, Liu L, Mahenthirlingam E. Disproportionate distribution of Burkholderia cepacia species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 2001; 164:92-96.
60. Heath DG, Hohnecker K, Carriker C, Smith K, Routh J, LiPuma JJ, et al. Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral centre for lung transplantation. J Clin Microbiol 2002; 40:1188-1193.
61. Butler SL, Doherty CJ, Hughes JE, Nelson JW, Govan JRW. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol 1995; 33:1001-1004.
62. Miller SCM, LiPuma JJ, Parke JL. Culture-based and non-growth-dependent detection of the Burkholderia cepacia complex in soil environments. Appl Environ Microbiol 2002; 68:3750-3758.
63. Balandreau J, Viallard V, Cournoyer B, Coenye T, Laevens S, Vandamme P. Burkholderia cepacia genomovar III is a common plant-associated bacterium. Appl Environ Microbiol 2001; 67:982-985.
64. Bevivino A, Dalmastri C, Tabacchioni S, Chiarini L, Belli ML, Piana S, et al. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol 2002; 40:846-851.
65. Millar-Jones L, Ryley HC, Paull A, Goodchild MC. Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients. Resp Med 1998; 92:178-183.
66. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002; 8:181-187.
67. Agodi A, Mahenthiralingam E, Barchitta M, Giannino V, Sciacca A, Stefani S. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol 2001; 39:2891-2896.
68. Clode FE, Kaufmann ME, Malnick H, Pitt TL. Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol 2000; 38:1763-1766.
69. Aaron SD, Ferris W, Henry DA, Speert DP, MacDonald NE. Multiple combination bacterial antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med 2000; 161:1206-1212.
70. Desai M, Bühler T, Weller PH, Brown MRW. Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth. J Antimicrobial Chemother 1998; 42:153-160.
71. Chen JS, Witzmann KA, Spilker T, Fink RJ, LiPuma JJ. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J Pediatr 2001; 139:643-649.
72. Cystic Fibrosis Trust Infection Control Group. A statement on Burkholderia cepacia. Bromley, UK: Cystic Fibrosis Trust; July 1999.
73. Ledson MJ, Gallagher MJ, Corkill JE, Hart CA, Walshaw MJ. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 1998; 53:432-436.
74. Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LTK, et al. Infection with Burkholderia cepacia complex genomovars in patients with transmissible strain genomovar III can replace Burkholderia multivorans. Clin Infect Dis 2001; 33:1469-1475.
75. Dobbin CJ, Soni R, Jelihovsky T, Bye PTP. Cepacia syndrome occurring following prolonged colonisation with Burkholderia cepacia. Aust N Z J Med 2000; 30:288-289.
76. Holsclaw DS. Immune complex disease in older patients with CF. Israel J Med Sci 1996; 32(suppl):S284-S285.
77. Kazachkov M, Lager J, LiPuma J, Barker PM. Survival following Burkhlolderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids. Pediatr Pulmonol 2001; 32: 338-340.
78. Frangolias DD, Mahenthiralingam E, Rae S, Raboud JM, Davidson AGF, Wittmann R, et al. Burkholderia cepacia in cystic fibrosis: variable disease course. Am J Respir Crit Care Med 1999; 160:1572-1577.
79. Ledson MJ, Gallagher MJ, Jackson M, Hart CA, Walshaw MJ. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 2002; 57:142-145.
80. Soni R, Marks G, Henry DA, Robinson M, Moriarty C, Parsons S, et al. Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: a pilot study in a Sydney clinic. Respirology 2002; 7:241-245.
81. LiPuma JJ. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? Transpl Infect Dis 2001; 3:149-160.
82. Aris RM, Routh JL, LiPuma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia: survival linked to genomovar type. Am J Respir Crit Care Med 2001; 164:2102-2106.
83. De Soyza A, McDowell A, Archer L, Dark JH, Elborn SJ, Mahenthiralingam E, et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001; 358:1780-1781.
84. Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Hoiby N, et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104:431-433.